Target Group Inc. (CBDY): Gross Profit

Annual figures by period end, from SEC filings.

$2.07M
Year ended 2025-12-31
$2.10M
Trailing 12 months to 2026-09-30
n/m
5-year compound annual growth
$3.73M2019-12-31: $02020-12-31: $5.0K2022-12-31: $02023-12-31: $1.66M2024-12-31: $3.73M2025-12-31: $2.07M$2.07M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$2.07M-44.5%2026-03-31, From 2025-01-01
2024-12-31$3.73M+125.1%2026-03-31, From 2024-01-01
2023-12-31$1.66Mn/a2025-03-27, From 2023-01-01
2022-12-31$0n/a2024-03-20, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31$5.0Kn/a2022-03-18, From 2020-01-01
2019-12-31$0n/a2021-03-30, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Target Group Inc. (CBDY)2025-12-31$2.07M-44.5%
Healthy Extracts Inc. (HYEX)2025-12-31$2.42M+26.7%
Functional Brands Inc. (MEHA)2025-12-31$3.48M-3.4%
TFA Therapeutics, Inc. (RAJAF)2025-12-31$760.7K-16.1%
Bon Natural Life Ltd (BON)2025-09-30$3.88M-45.4%
Charlie's Holdings, Inc. (CHUC)2025-12-31$5.66M+96.6%
Adia Med, Inc. (ADIA)2025-12-31$191.7Kn/m
Cyanotech Corp (CYAN)2025-03-31$6.88M+15.7%
C21 Investments Inc. (CWLXF)2026-03-31$13.61M+8.3%

Compare CBDY, HYEX, MEHA, RAJAF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗